Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming

Will this pharma company become a new leader in the weight loss market?

CryptoAlerta — análise de criptomoedas e mercado em tempo real